NEW YORK (AP) - The U.S. Food and Drug Administration has ratcheted up its warning about the potential side effects of a class of commonly-prescribed powerful antibiotic, including the drug known by the brand name Cipro.
In a safety announcement issued Thursday, the FDA said the potential side effects of fluoroquinolone anti-bacterial drugs often outweigh their benefits when it comes to treating people with bronchitis or basic sinus or urinary tract infections.
FDA: Cipro side effects outweigh benefit for some infections
Aucun commentaire:
Enregistrer un commentaire